Birker.o slashed.d, Denmark

Niels Erik Holm

This inventor holds 43 USPTO granted patents and 5 published patent applications, plus 14 CIPO patents and 8 EPO patents, primarily in Blood Product Processing. Top assignees: Bristol-Myers Squibb Compnay, E. R. Squibb Sons, Inc., Reapplix Aps. Active years: 1987-2024.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Niels Erik Holm. Retrieved from https://idiyas.com/inventor/niels-erik-holm

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 43 

% Patents Active = 100.0

 

 

Average Co-Inventor Count = 1.4

ph-index = 25

Forward Citations = 1,884(Granted Patents)


Location History:

  • Soroe, DK (1987)
  • Birkerd, DK (1991)
  • 3460 Birkerod, DK (1994)
  • DK-3460 Brikerod, DK (1995)
  • DK-3460 Birkerod, DK (1996)
  • Birkeroed, DK (1997)
  • Blokken, DK (1998 - 1999)
  • Birker.o slashed.d, DK (1997 - 2000)
  • Birkerod, DK (1990 - 2024)
  • Birkerød, DK (2001 - 2024)

Company Filing History:


Years Active: 1987-2024

Loading Chart...
Loading Chart...
Loading Chart...
Areas of Expertise:
Blood Product
Centrifuge
Multilayered Blood Product
Separation Process
Coagulation Factors
Biomaterial
Centrifugal Filtration
Fluid Separation
Blood Plasma
Dispensing Device
Temperature Control
Optical Detection
43 patents (USPTO):Explore Patents

Title: Innovations by Niels Erik Holm: Pioneering Advances in Blood Collection and Products

Introduction: Niels Erik Holm, based in Birkerød, Denmark, is a notable inventor with a remarkable portfolio of 38 patents. His innovative work has significantly contributed to the field of blood collection and processing, leading to advancements that enhance patient care and surgical outcomes.

Latest Patents: Among Holm's latest patents is a revolutionary blood collection unit designed for accelerated blood coagulation of whole blood. This unit is adaptable for subsequent autologous or allogeneic use and incorporates an inside surface with a high roughness activation site, promoting rapid coagulation. Furthermore, Holm has patented a multilayered blood product that utilizes components from whole blood, including fibrin, thrombocytes, and leukocytes. This product consists of three distinct layers, each engineered to optimize the functional properties of the blood components, enhancing their therapeutic potential.

Career Highlights: Niels Erik Holm has had an influential career, marked by his tenure at prominent pharmaceutical and biotechnology firms, including Bristol-Myers Squibb Company and E.R. Squibb & Sons, Inc. His dedication and innovative spirit have driven advancements in the medical field, showcasing his expertise in creating efficient solutions for blood management.

Collaborations: Throughout his career, Holm has collaborated with esteemed colleagues such as Rasmus Lundquist and Glenn A. Jorgensen. These partnerships have facilitated the exchange of ideas, enriching the development of groundbreaking technologies in blood processing and therapy.

Conclusion: Niels Erik Holm stands out as a significant figure in the realm of medical innovations, particularly related to blood collection and products. His 38 patents reflect his commitment to improving medical practices and patient outcomes. As technology continues to evolve, Holm's contributions will likely inspire future advancements in the field.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…